Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In the case reported by Sani et al
Oral semaglutide works by activating GLP-1 receptors in the brain, reducing hunger, and promoting a sense of fullness, while also slowing gastric emptying to prolong satiety
However, in individuals suffering from different neurodevelopmental disorder conditions, including ASD, these pathways can be hyperactivated, causing irreversible damage to the organism
Accessed at www.healthline.com/health-news/wegovy-zepbound-myths-debunked
*Correspondence: Weina Li, [email protected] Meng Li, [email protected] These authors have contributed equally to this work This article was submitted to Drug Metabolism and Transport, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
